Cargando…
Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897876/ https://www.ncbi.nlm.nih.gov/pubmed/33619243 http://dx.doi.org/10.1038/s41392-021-00497-4 |
| _version_ | 1783653754468302848 |
|---|---|
| author | Xie, Chen Chen, Yanlian Luo, Dongling Zhuang, Zhen Jin, Heping Zhou, Haoxian Li, Xiaocui Lin, Haijun Zheng, Xiaohui Zhang, Jing Wang, Peihui Zhao, Jincun Zhao, Yong Huang, Hui |
| author_facet | Xie, Chen Chen, Yanlian Luo, Dongling Zhuang, Zhen Jin, Heping Zhou, Haoxian Li, Xiaocui Lin, Haijun Zheng, Xiaohui Zhang, Jing Wang, Peihui Zhao, Jincun Zhao, Yong Huang, Hui |
| author_sort | Xie, Chen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7897876 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78978762021-02-22 Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 Xie, Chen Chen, Yanlian Luo, Dongling Zhuang, Zhen Jin, Heping Zhou, Haoxian Li, Xiaocui Lin, Haijun Zheng, Xiaohui Zhang, Jing Wang, Peihui Zhao, Jincun Zhao, Yong Huang, Hui Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-02-22 /pmc/articles/PMC7897876/ /pubmed/33619243 http://dx.doi.org/10.1038/s41392-021-00497-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Xie, Chen Chen, Yanlian Luo, Dongling Zhuang, Zhen Jin, Heping Zhou, Haoxian Li, Xiaocui Lin, Haijun Zheng, Xiaohui Zhang, Jing Wang, Peihui Zhao, Jincun Zhao, Yong Huang, Hui Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 |
| title | Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 |
| title_full | Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 |
| title_fullStr | Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 |
| title_full_unstemmed | Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 |
| title_short | Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7 |
| title_sort | therapeutic potential of c1632 by inhibition of sars-cov-2 replication and viral-induced inflammation through upregulating let-7 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897876/ https://www.ncbi.nlm.nih.gov/pubmed/33619243 http://dx.doi.org/10.1038/s41392-021-00497-4 |
| work_keys_str_mv | AT xiechen therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT chenyanlian therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT luodongling therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT zhuangzhen therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT jinheping therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT zhouhaoxian therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT lixiaocui therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT linhaijun therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT zhengxiaohui therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT zhangjing therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT wangpeihui therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT zhaojincun therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT zhaoyong therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 AT huanghui therapeuticpotentialofc1632byinhibitionofsarscov2replicationandviralinducedinflammationthroughupregulatinglet7 |